Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Ansell.
RELATED STOCKHEAD STORIES
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise but are ‘lacking any momentum’
Health & Biotech
ScoPo’s Powerplays: ASX health stocks hit resistance in first week of FY25
Health & Biotech
ASX Health Stocks: Immuron gives vicious cycle kick in the guts
News
Traders’ Diary: Everything you need to get ready for the week ahead
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise, Mach7 eyes cashflow positive in FY24
News
Closing Bell: ASX gains as lithium, iron ore miners dazzle; copper and gold stocks extend rally
News
ASX Small Caps Lunch Wrap: Which country’s gone full-on Footloose this week?
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Large Caps: ANZ and Suncorp get merger approval, Star crashes 22pc after revealing second probe
Health & Biotech
ScoPo’s Powerplays: ASX health stocks tumble as CSL bleeds after Phase III trial misses endpoint
Experts
MoneyTalks: The Greatest Wealth is Health, says Morningstar’s Shane Ponraj and Virgil
Health & Biotech
ScoPo’s Powerplays: ASX health stock fall but hold onto your hat for reporting season
News
Closing Bell: Hawkish RBA helps extend ASX losses; Indiana Resources surges as Ansell tanks
News
ASX Large Caps: Shares fall 0.25pc; Ansell tumbles 14pc on weak guidance
News
Top 10 at 10: Tiny explorer announces US$70m payday, condom maker droops on poor guidance
Experts
FREE WHELAN: Japan, India or China; And the best ASX bad stock list money can’t buy
Health & Biotech
